2,130
Participants
Start Date
November 30, 2004
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
Lapaquistat acetate
Lapaquistat acetate 100 mg, tablets, orally, once daily and Atorvastatin placebo-matching capsules, orally, once daily for up to 96 weeks.
Lapaquistat acetate and atorvastatin
Lapaquistat acetate 100 mg, tablets, orally, once daily and Atorvastatin 10 mg, capsules, orally, once daily for up to 96 weeks.
Atorvastatin
Lapaquistat acetate placebo-matching tablets, orally, once daily and Atorvastatin 10 mg, capsules, orally, once daily for up to 96 weeks.
Birmingham
Mobile
Northport
Chandler
Phoenix
Sierra Vista
Jonesboro
Little Rock
Anaheim
Rancho Cucamonga
Santa Rosa
Golden
Coral Gables
Fort Myers
Jacksonville
Sarasota
West Palm Beach
Dunwoody
Boise
Idaho Falls
Arlington Heights
Chicago
Elk Grove Village
Evansville
Indianapolis
Waterloo
Kansas City
Overland Park
Louisville
New Orleans
Flint
Edina
St Louis
Omaha
Ship Bottom
Rochester
Syracuse
Charlotte
Statesville
Wilmington
Winston-Salem
Cincinnati
Tulsa
Philadelphia
Tipton
Anderson
Mt. Pleasant
Simpsonville
Cordova
Morristown
Corpus Christi
Dallas
Fort Worth
Houston
Plano
San Antonio
Temple
Texarkana
Norfolk
Richmond
Lakewood
Buenos Aires
Córdoba
La Plata
Morón
Pilar
Rosario
Salta
Santa Fe
Santiago
Brno
Olomouc
Prague
Tartu
Berlin
Freiburg im Breisgau
Görlitz
Hamburg
Mannheim
Mönchengladbach
Munich
Schwerin
Budapest
Debrecen
Esztergom
Győr
Gyula
Kecskemét
Warszawa
Riga
Kaunas
Vilnius
Vilnius-21
Distrito Federal
Guadalajara
Jalisco
Mexico City
San Luis Potosí City
Zapopan
Es Velp
Groningen
Leiden
Rotterdam
Zoetermeer
Lima
Bialystok
Bydgoszcz
Gdansk
Gorzów Wielkopolski
Grudziądz
Płońsk
Torun
Wroclaw
Włocławek
Moscow
Saint Petersburg
Saratov
Komárno
Košice
Levice
Cape Town
Johannesburg
Parow
Western Cape
Truro
Blackpool
Bolton
Guildford
Lead Sponsor
Takeda
INDUSTRY